June 22, 2016   NEW YORK–(BUSINESS WIRE)–PAVmed Inc. (Nasdaq:PAVMU), an innovative multi-product medical device company, today announced the successful completion of a pre-clinical human cadaver study, demonstrating that the Company’s completely percutaneous CarpX™ device reliably and effectively transects the ligament which causes Carpal Tunnel Syndrome (CTS). Lishan Aklog, M.D., Chairman and CEO of PAVmed, said […]